Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
NAFDAC is intensifying regulatory oversight through new enforcement actions, capacity building, and stakeholder training, while also issuing alerts on substandard and falsified medicines. For Nigerian SMBs in healthcare, pharmaceuticals, and related sectors, this means stricter compliance requirements, potential supply chain disruptions, and a need for heightened vigilance. Additionally, export-oriented businesses like fish farms must navigate registration with NEPC to access international markets.
Pharmaceuticals and Healthcare
Importation and Distribution
Retail and PPMVs
Export and Agriculture
Clinical Research
Inauguration Ceremony of the NAFDAC Pharmacist Reserve Group
NAFDAC
NAFDAC inaugurated 600 pharmacists into a voluntary reserve group to enhance regulatory capacity and service delivery.
SMBs in pharmaceutical distribution may benefit from increased regulatory support and faster processing, but should also prepare for more rigorous inspections and compliance checks.
NAFDAC and NHREC Announce New Dates for Mandatory Stakeholders Training on Clinical Trial Regulations in Nigeria
NAFDAC
NAFDAC and NHREC rescheduled mandatory training on clinical trial regulations for stakeholders.
SMBs involved in clinical trials or research must ensure their staff attend the training to remain compliant, potentially affecting timelines and costs.
Public Notice on Blacklisting Ayrtons Saunders Ltd, UK
NAFDAC
NAFDAC blacklisted Ayrtons Saunders Ltd, UK, and its products, warning against importation, distribution, or sale.
SMBs importing or distributing products from this company must immediately cease and verify their supply chains to avoid penalties and product seizures.
Public Alert No. 043/2026: NAFDAC Places Products Marketed by Mofus Nigeria Ltd on Watchlist
NAFDAC
NAFDAC placed products marketed by Mofus Nigeria Ltd on a watchlist pending regulatory investigation.
Retailers, distributors, and PPMVs should quarantine these products and await further directives to avoid regulatory action.
Public Alert No. 042/2026: Alert on the Seizure of Suspected Substandard and Falsified BPPL Artemether/Lumefantrine 80mg/480mg
NAFDAC
NAFDAC seized suspected substandard and falsified antimalarial medicine BPPL Artemether/Lumefantrine 80mg/480mg.
Healthcare providers and pharmacies must remove this product from shelves and report any sightings to NAFDAC to protect patients and avoid liability.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide
Other
A guide on registering fish farms with NEPC for export purposes.
SMBs in aquaculture seeking to export must complete NEPC registration to access international markets, ensuring compliance with export regulations.
Increased regulatory scrutiny on pharmaceutical imports and distribution.
Mandatory training for clinical trial stakeholders may affect research-based SMBs.
Blacklisted and watchlisted products require immediate supply chain audits.
Export opportunities for fish farms require NEPC registration.
NAFDAC's reserve group may lead to more frequent inspections and enforcement.
1
Review supply chains to ensure no products from blacklisted or watchlisted companies are stocked.
2
Attend NAFDAC/NHREC mandatory training on clinical trial regulations if involved in research.
3
Remove and report substandard/falsified BPPL Artemether/Lumefantrine 80mg/480mg.
4
Register fish farms with NEPC for export compliance.
5
Stay updated on NAFDAC public alerts and notices to avoid penalties.